Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Gastrointestinal Stromal Tumors 2 Colorectal Neoplasms 2 Biliary Tract Neoplasms 2 Advanced or Metastatic Solid Tumors 2 Thymoma 1 Solid Tumor 1 Sarcoma 1 Piebaldism 1 Osteosarcoma 1 Nasopharyngeal Carcinoma 1 Endometrial Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 Advanced Solid Tumor 1 Advanced Renal Cell Carcinoma (aRCC) 1 Advanced Refractory Solid Tumors 1

Interventions

pembrolizumab 4 Cyclophosphamide 4 Radiotherapy 3 Cisplatin 3 fludarabine 2 Doxorubicin 2 Carboplatin 2 zimberelimab 1 olaparib 1 lenvatinib 1 envafolimab 1 avelumab 1 Thymectomy 1 Taxes 1 Sunitinib 1 Robotic Surgical Procedures 1 Ramucirumab 1 Radiotherapy, Adjuvant 1 Paclitaxel 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Etoposide 1 Drug Therapy 1 Chemoradiotherapy 1 Cetuximab 1 AP 1903 reagent 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Thymoma × envafolimab × 1 year × Clear all

NCT06019468 2026-05-08

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Recruiting

Thymoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡